GlassScriptPhysician profile
Puja Sharma
NPI 1225364821
$1,123.61
in general payments reported to CMS, 2019-2025
19 companies · $184 in 2025
The $184 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.39 · 2020: $13.84 · 2021: $274 · 2022: $323 · 2023: $39.48 · 2024: $201 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $424.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $266.29 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $111.32 | 2021-2025 | Zepbound, Jardiance |
| Abbvie INC. | $99.11 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $73.54 | 2022 | |
| Eisai INC. | $69.99 | 2021-2022 | |
| Glaxosmithkline, LLC. | $58.29 | 2022-2025 | Shingrix, Arexvy, Bexsero |
| Alkermes, INC. | $56.64 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $55.41 | 2021-2022 | |
| Pfizer INC. | $54.76 | 2021-2022 | |
| Indivior INC. | $44.22 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.06 | 2021-2024 | Jardiance, Synjardy |
| Novartis Pharmaceuticals Corporation | $35.91 | 2022 | |
| Dynavax Technologies Corporation | $32.63 | 2024 | Heplisav-B |
| Sanofi Pasteur INC. | $27.16 | 2019-2020 | |
| Exact Sciences Corporation | $25.35 | 2023 | Cologuard Collection Kit |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $23.38 | 2021 | |
| Esperion Therapeutics, INC. | $16.51 | 2025 | Nexletol |
| Abbott Laboratories | $15.46 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $13.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Puja Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.